Task: Answer the MCQ question.
Query: Which compound exhibits a -50.506% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
[a] O=c1c2c(n3nnnc3n1Cc1ccccc1)-c1ccccc1CC21CCCC1
[b] CCCOc1ccc(NC(=O)CC2C(=O)N(CC)C(=S)N2CCCN2CCN(Cc3ccccc3)CC2)cc1
Answer: b. CCCOc1ccc(NC(=O)CC2C(=O)N(CC)C(=S)N2CCCN2CCN(Cc3ccccc3)CC2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCOc1ccc(NC(=O)CC2C(=O)N(CC)C(=S)N2CCCN2CCN(Cc3ccccc3)CC2)cc1
CCCOc1ccc(NC(=O)CC2C(=O)N(CC)C(=S)N2CCCN2CCN(Cc3ccccc3)CC2)cc1
2-[3-[3-(4-benzylpiperazin-1-yl)propyl]-1-ethyl-5-oxo-2-sulfanylideneimidazolidin-4-yl]-N-(4-propoxyphenyl)acetamide